Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Controlling spending in your 20s comes down to consistent routines: track, limit impulse buys, and automate saving to reinforce discipline.
21,066 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
As the economy ebbs and flows, some stocks stand out for their hard-to-replace value. This piece explores why costco ...
A transformative update could reshape Micron stock dynamics. This guide breaks down what the news might mean, how to ...
As AI accelerates, investors weigh NVIDIA and AMD to find the better chip. This guide breaks down the AI chip race, v...
Tech leadership returned to the forefront as semiconductors boosted Nasdaq in July trading. This article breaks down ...
A fresh inflation outlook from the FED just arrived in May, and markets moved on the news. This article breaks down w...
As oil markets swing, Noble and Transocean stand out in the offshore drilling arena. This guide breaks down which off...
A major tech partnership and improving chip demand helped Intel stock climb sharply on Thursday. This deep dive expla...
Meta just made striking moves in AI infrastructure that could tilt demand in Nvidia's favor. This deep dive explains ...
Old Dominion Freight Line (ODFL) faced an 11.9% drop after a Citi downgrade, despite strong fundamentals. This articl...
The software sector has faced a sharp pullback, but not all names belong in the same bucket. This guide highlights ho...
Palantir stock today climbed as the company announced a strategic AI collaboration. This article breaks down the driv...